LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 67 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,697,329 | +2597.3% | 682,868 | +1223.2% | 0.32% | +1700.0% |
Q2 2022 | $100,000 | -52.2% | 51,606 | 0.0% | 0.02% | -33.3% |
Q1 2022 | $209,000 | -59.0% | 51,606 | +9.4% | 0.03% | -64.5% |
Q4 2021 | $510,000 | -6.4% | 47,193 | 0.0% | 0.08% | +100.0% |
Q3 2021 | $545,000 | +4.8% | 47,193 | -10.9% | 0.04% | -9.5% |
Q2 2021 | $520,000 | -91.6% | 52,968 | -87.5% | 0.04% | -79.9% |
Q1 2021 | $6,215,000 | – | 425,384 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |